AYTU · NASDAQ
Aytu BioPharma (AYTU) Stock Price & Fundamentals
Aytu BioPharma (AYTU) closed at $508.31 on Oct 9, 2026, up 1.22% from the previous close of $502.18.
Share price, past year
1Y −2.39%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $508.31 |
| Sep 30, 2026 | $510.00 |
| Aug 31, 2026 | $496.08 |
| Jul 31, 2026 | $453.57 |
| Jun 30, 2026 | $465.37 |
| May 29, 2026 | $489.19 |
| Apr 30, 2026 | $502.45 |
| Mar 31, 2026 | $492.01 |
| Feb 27, 2026 | $531.18 |
| Jan 30, 2026 | $510.33 |
| Dec 31, 2025 | $509.48 |
| Nov 28, 2025 | $510.32 |
| Oct 31, 2025 | $493.16 |
Key statistics
- Market cap
- $5.45B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $57.57M
- Net income (TTM)
- −$14.25M
- Shares outstanding
- 10.7M
- Dividend yield
- —
- 52-week range
- $446.76 – $539.06
Aytu BioPharma's market cap is $5.45B, based on a share price of $508.31 and 10.7M shares outstanding as of Jun 30, 2026.
Financials
Aytu BioPharma reported revenue of $57.57M for fiscal 2026, down 13.27% from fiscal 2025.
Aytu BioPharma reported a net loss of $14.25M in fiscal 2026.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Jun 30, 2026 | $57.57M | −13.3% | −$14.25M | −24.8% | — | $3.25M |
| FY2025ended Jun 30, 2025 | $66.38M | +1.8% | −$13.56M | −20.4% | — | −$2.17M |
| FY2024ended Jun 30, 2024 | $65.18M | −39.3% | −$15.84M | −24.3% | — | −$1.72M |
| FY2023ended Jun 30, 2023 | $107.40M | +11.1% | −$17.05M | −15.9% | −$5.11 | — |
| FY2022ended Jun 30, 2022 | $96.67M | +47.3% | −$108.78M | −112.5% | −$74.01 | — |
| FY2021ended Jun 30, 2021 | $65.63M | +137.5% | −$58.29M | −88.8% | −$69.60 | — |
| FY2020ended Jun 30, 2020 | $27.63M | +277.5% | −$13.62M | −49.3% | −$60.20 | −$28.37M |
| FY2019ended Jun 30, 2019 | $7.32M | +100.0% | −$27.13M | −370.6% | −$69.60 | −$13.89M |
| FY2018ended Jun 30, 2018 | $3.66M | +13.6% | −$10.19M | −278.4% | −$306.20 | −$16.02M |
| FY2017ended Jun 30, 2017 | $3.22M | — | −$22.51M | −698.7% | −$966.00 | −$13.94M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2026ended Jun 30, 2026 | $16.11M | −$15.00K | — |
| Q3 FY2026ended Mar 31, 2026 | $12.41M | −$5.62M | −$0.53 |
| Q2 FY2026ended Dec 31, 2025 | $15.17M | −$10.58M | −$1.05 |
| Q1 FY2026ended Sep 30, 2025 | $13.89M | $1.97M | −$0.08 |
| Q4 FY2025ended Jun 30, 2025 | $15.14M | −$19.82M | — |
| Q3 FY2025ended Mar 31, 2025 | $18.45M | $3.99M | $0.21 |
| Q2 FY2025ended Dec 31, 2024 | $16.22M | $788.00K | −$0.26 |
| Q1 FY2025ended Sep 30, 2024 | $16.57M | $1.47M | −$0.15 |
Company profile
- Name
- Aytu BioPharma, Inc.
- Ticker
- AYTU
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 7900 E. Union Avenue, Suite 920, Denver, CO 80237
- Incorporated in
- DE
- Fiscal year ends
- June
- SEC CIK
- 0001385818
Recent SEC filings
- Sep 22, 2026
- Sep 22, 2026
- Jun 25, 2026
- May 13, 2026
- May 13, 2026
- Apr 2, 2026
- Feb 3, 2026
- Feb 3, 2026
Frequently asked questions
What is Aytu BioPharma's stock price?
Aytu BioPharma (AYTU) closed at $508.31 on Oct 9, 2026, up 1.22% from the previous close of $502.18.
What is Aytu BioPharma's market cap?
Aytu BioPharma's market cap is $5.45B, based on a share price of $508.31 and 10.7M shares outstanding as of Jun 30, 2026.
How much revenue does Aytu BioPharma make?
Aytu BioPharma reported revenue of $57.57M for fiscal 2026, down 13.27% from fiscal 2025.
Does Aytu BioPharma pay a dividend?
Aytu BioPharma's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Aytu BioPharma, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures